View |
|
DRP-14595-04
|
Acetylcysteine
|
Pulmocass 600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
07 July 2024
|
20 October 2028
|
View |
|
DRP-14595-05
|
Acetylcysteine
|
Gotyl-600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
07 July 2024
|
20 October 2028
|
View |
|
DRP-14678-01
|
Multivitamins + Iron
|
VitaPlus
|
(See reverse for formulation)
|
Capsule
|
Vitamins/Mineral
|
AZARIAS PHARMACEUTICAL LABORATORIES INC.
|
India
|
CLIDP Conversion
|
10 July 2024
|
28 November 2028
|
View |
|
DRP-14708-02
|
Acetylcysteine
|
Chocoflem
|
600 mg per sachet
|
Powder for Oral Solution
|
Mucolytic
|
Unicure Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
07 July 2024
|
01 December 2028
|
View |
|
DRP-14864-01
|
Sevelamer Carbonate
|
Fosfamer
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 July 2024
|
25 June 2029
|
View |
|
DRP-14895-01
|
Abiraterone acetate
|
Abitrone
|
250 mg
|
Tablet
|
Endocrine Therapy (Hormone Antagonist and Related Agent)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
07 July 2024
|
13 February 2029
|
View |
|
DRP-14998-01
|
Amiodarone hydrochloride
|
Cenoron
|
50 mg/mL (150 mg/3 mL)
|
Concentrate Solution for Injection (IV)
|
Anti-arrhythmic
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
CLIDP Conversion
|
07 July 2024
|
07 March 2029
|
View |
|
DRP-15068-01
|
Hydroxychloroquine Sulfate
|
Hydroxyjac
|
200 mg
|
Film-Coated Tablet
|
Antimalarial (Aminoquinolines)
|
Bafna Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
07 July 2024
|
04 April 2029
|
View |
|
DRP-15174
|
Aceclofenac + Paracetamol
|
Dolowin Plus
|
100 mg /500 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-inflammatory Drug / Analgesic / Antipyretic
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
11 July 2024
|
21 November 2029
|
View |
|
DRP-15210-01
|
Co-Amoxiclav
|
Goclav 228
|
228.5 mg / 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin / Beta-lactamase Inhibitor)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 July 2024
|
28 May 2029
|
View |
|
DRP-1538-10
|
Diphenhydramine Hydrochloride
|
Nadrexol
|
12.5 mg/5 mL
|
Syrup
|
H1-Receptor Antagonist (Antihistamine)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
07 July 2024
|
02 January 2027
|
View |
|
DRP-163-06
|
Multivitamins
|
Nervcee
|
(see reverse for formulation)
|
Capsule
|
Multivitamins
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
CLIDP Conversion
|
10 July 2024
|
04 November 2027
|
View |
|
DRP-176-13
|
Multivitamins + Iron
|
Alertmax
|
|
Capsule
|
Vitamins / Mineral
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
CLIDP Conversion
|
10 July 2024
|
14 April 2028
|
View |
|
DRP-2045-03
|
Fluconazole
|
Flucon
|
150 mg
|
Capsule
|
Antifungal
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP
|
28 May 2021
|
23 March 2025
|
View |
|
DRP-286-04
|
Mefenamic Acid
|
Memaray
|
500 mg
|
Capsule
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Flamingo Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
07 July 2024
|
02 May 2027
|
View |
|
DRP-3016-03
|
Omeprazole
|
Omepracent 40
|
40 mg
|
Capsule
|
Proton Pump Inhibitor
|
Windlas Biotech Limited
|
India
|
CLIDP Conversion
|
11 July 2024
|
02 June 2028
|
View |
|
DRP-3522-11
|
Cetirizine Hydrochloride
|
Erazin
|
5 mg/5 mL
|
Syrup
|
H1-Receptor Antagonist (Antihistamine)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
01 July 2024
|
01 February 2027
|
View |
|
DRP-4507-08
|
Celecoxib
|
Maedicoxib
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
LifeSquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
12 July 2024
|
04 October 2026
|
View |
|
DRP-4762-10
|
Telmisartan
|
Zermisar
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
08 July 2024
|
30 September 2028
|
View |
|
DRP-4765-09
|
Telmisartan
|
Zermisar
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Ltd.
|
India
|
CLIDP Conversion
|
08 July 2024
|
30 September 2028
|